Teacher Retirement System Of Texas Karuna Therapeutics, Inc. Transaction History

Teacher Retirement System Of Texas

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$161.01 - $317.85 $264,861 - $522,863	-1,645 Reduced 18.18%	7,402 $2.34 Million
Q3 2023 Oct 31, 2023	BUY	$164.66 - $218.08 $153,957 - $203,904	935 Added 11.53%	9,047 $1.53 Million
Q2 2023 Jul 19, 2023	SELL	$176.32 - $240.22 $62,946 - $85,758	-357 Reduced 4.22%	8,112 $1.76 Million
Q1 2023 May 12, 2023	BUY	$161.33 - $204.36 $71,791 - $90,940	445 Added 5.55%	8,469 $1.54 Million
Q4 2022 Feb 10, 2023	SELL	$191.53 - $236.82 $135,220 - $167,194	-706 Reduced 8.09%	8,024 $1.58 Million
Q3 2022 Nov 03, 2022	BUY	$123.79 - $277.42 $629,595 - $1.41 Million	5,086 Added 139.57%	8,730 $1.96 Million
Q2 2022 Aug 09, 2022	SELL	$93.97 - $143.33 $64,463 - $98,324	-686 Reduced 15.84%	3,644 $461,000
Q1 2022 May 09, 2022	BUY	$98.9 - $132.37 $28,878 - $38,652	292 Added 7.23%	4,330 $549,000
Q4 2021 Feb 10, 2022	BUY	$110.64 - $159.4 $88,843 - $127,998	803 Added 24.82%	4,038 $529,000
Q3 2021 Nov 09, 2021	BUY	$101.2 - $125.87 $81,870 - $101,828	809 Added 33.35%	3,235 $396,000
Q2 2021 Aug 05, 2021	BUY	$107.45 - $135.95 $260,673 - $329,814	2,426 New	2,426 $277,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Teacher Retirement System Of Texas with notifications on news.